South-Eastern Asia: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in South-Eastern Asia

The Southeast Asian market for other medicaments for therapeutic or prophylactic uses amounted to $X in 2022, rising by X% against the previous year. The total consumption indicated a buoyant increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in South-Eastern Asia

In value terms, production of other medicaments for therapeutic or prophylactic uses totaled $X in 2022 estimated in export price. In general, production enjoyed a buoyant expansion. The pace of growth appeared the most rapid in 2015 with an increase of X%. The level of production peaked in 2022 and is expected to retain growth in years to come.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in South-Eastern Asia

For the third consecutive year, South-Eastern Asia recorded growth in overseas shipments of other medicaments for therapeutic or prophylactic uses, which increased by X% to X tons in 2022. Overall, exports recorded a significant increase. The growth pace was the most rapid in 2021 when exports increased by X%. The volume of export peaked in 2022 and is likely to see gradual growth in the near future.

In value terms, exports of other medicaments for therapeutic or prophylactic uses dropped to $X in 2022. Over the period under review, exports enjoyed a buoyant increase. The most prominent rate of growth was recorded in 2018 when exports increased by X% against the previous year. The level of export peaked at $X in 2021, and then reduced in the following year.

Exports by Country

In 2022, Singapore (X tons) was the main exporter of other medicaments for therapeutic or prophylactic uses, comprising X% of total exports. It was distantly followed by Brunei Darussalam (X tons), committing a X% share of total exports. Thailand (X tons) held a little share of total exports.

From 2012 to 2022, average annual rates of growth with regard to other medicaments for therapeutic or prophylactic uses exports from Singapore stood at X%. At the same time, Brunei Darussalam (X%) and Thailand (X%) displayed positive paces of growth. Moreover, Brunei Darussalam emerged as the fastest-growing exporter exported in South-Eastern Asia, with a CAGR of X% from 2012-2022. Singapore (X p.p.) and Brunei Darussalam (X p.p.) significantly strengthened its position in terms of the total exports, while Thailand saw its share reduced by X% from 2012 to 2022, respectively.

In value terms, Singapore ($X) remains the largest other medicaments for therapeutic or prophylactic uses supplier in South-Eastern Asia, comprising X% of total exports. The second position in the ranking was taken by Thailand ($X), with a X% share of total exports.

In Singapore, exports of other medicaments for therapeutic or prophylactic uses expanded at an average annual rate of X% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: Thailand (X% per year) and Brunei Darussalam (X% per year).

Export Prices by Country

In 2022, the export price in South-Eastern Asia amounted to $X per ton, waning by X% against the previous year. Over the period under review, the export price saw a abrupt shrinkage. The pace of growth was the most pronounced in 2018 when the export price increased by X% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2020; however, from 2021 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Singapore ($X per ton), while Brunei Darussalam ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Thailand (X%), while the other leaders experienced a decline in the export price figures.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in South-Eastern Asia

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported in South-Eastern Asia stood at X tons, growing by X% compared with 2021. Over the period under review, imports recorded a relatively flat trend pattern. The growth pace was the most rapid in 2017 when imports increased by X%. As a result, imports attained the peak of X tons. From 2018 to 2022, the growth of imports of remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses reduced to $X in 2022. Total imports indicated a mild expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2020 when imports increased by X% against the previous year. As a result, imports attained the peak of $X. From 2021 to 2022, the growth of imports of failed to regain momentum.

Imports by Country

In 2022, Thailand (X tons), distantly followed by Malaysia (X tons), Vietnam (X tons), Indonesia (X tons) and Myanmar (X tons) were the major importers of other medicaments for therapeutic or prophylactic uses, together constituting X% of total imports. The following importers - the Philippines (X tons) and Singapore (X tons) - each reached an X% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Myanmar (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Thailand ($X) constitutes the largest market for imported other medicaments for therapeutic or prophylactic uses in South-Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by Indonesia ($X), with an X% share of total imports. It was followed by Malaysia, with a X% share.

In Thailand, imports of other medicaments for therapeutic or prophylactic uses increased at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Indonesia (X% per year) and Malaysia (X% per year).

Import Prices by Country

In 2022, the import price in South-Eastern Asia amounted to $X per ton, dropping by X% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of X%. The pace of growth was the most pronounced in 2018 when the import price increased by X%. The level of import peaked at $X per ton in 2016; however, from 2017 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Singapore ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Myanmar (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :